US FDA Staff Question Allos Therapeutics, Inc. Lymphoma Drug Data
Reuters -- U.S. drug reviewers questioned findings from biotech company Allos Therapeutics Inc on the effectiveness of its proposed drug for an aggressive type of lymphoma, documents released on Friday showed.